Le Lézard
Classified in: Science and technology
Subjects: CCA, ACC

Invitation to Electrolux Group Q2 presentation


STOCKHOLM, July 7, 2023 /PRNewswire/ -- Electrolux Group results for the second quarter of 2023 will be published on July 20, 2023, at approx. 08.00 CEST.

A telephone conference will be held following the release of the results, starting at 09.00 CEST.

Jonas Samuelson, President and CEO, Therese Friberg, CFO, and Anna Ohlsson-Leijon, CCO, will comment on the report. Information on how to join the telephone conference is available HERE.

Slides used in the presentation and report will be available at the Group's website, www.electroluxgroup.com/ir.

For further information, please contact:
Sophie Arnius, Investor Relations, +46 70 590 80 72
Electrolux Group Press Hotline, +46 8 657 65 07

The following files are available for download:

https://mb.cision.com/Main/1853/3801087/2176373.pdf

Invitation Q2 2023

 

SOURCE Electrolux


These press releases may also interest you

at 01:39
MetaComp Pte Ltd, a leading Monetary Authority of Singapore (MAS) licensed Singapore fintech company that specializes in blockchain technology and digital assets, and its affiliates (collectively referred as MetaComp), is proud to announce a...

at 01:05
Elliptic Labs (OSE: ELABS), a global AI software company and the world leader in AI Virtual Smart Sensorstm currently deployed in over 500 million devices, is shipping its AI Virtual Proximity Sensortm INNER BEAUTY® on the newly announced Moondrop...

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:49
A news report from chinadaily.com.cn: Young people play a pivotal role in innovation and deserve more support that encourages them to...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...



News published on and distributed by: